Latest debt-to-equity ratio
Nektar Therapeutics Debt-to-equity ratio
Direct answer
Nektar Therapeutics's debt-to-equity ratio is 15.05%.
The verified market snapshot reports 15.05%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 15.05%
Explore related company data
View Nektar Therapeutics's market capitalizationView Nektar Therapeutics's price-to-book ratioView Nektar Therapeutics's return on equityView Nektar Therapeutics's dividend yieldView Nektar Therapeutics's 52-week price rangeView Nektar Therapeutics's revenue growthView Nektar Therapeutics's profit marginView all Nektar Therapeutics key metricsReturn to Nektar Therapeutics profile